Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fletcher

Showing results (571-580 of 601) with videos related to

Pageof 61
Sort By:
Scientific Reports|March 31, 2018
Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytesJulie Lucifora, Marc Bonnin, Ludovic Aillot, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2024
Selective depletion of HBV-infected hepatocytes by class A capsid assembly modulators requires high levels of intrahepatic HBV core proteinDmytro Kornyeyev, Zhijuan Song, Stacey Eng, et al.
JHEP Reports : Innovation in Hepatology|March 11, 2026
Spatial transcriptional profiling of CHB liver biopsies reveals an undetected population of zonally biased HBV-integrated cellsSangeetha Mahadevan, Ricardo Ramirez, Hatef Mehrabian, et al.
The Journal of Infectious Diseases|August 21, 2023
Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus-Specific CD8 T-Cell Responses and High Anti-Hepatitis B Surface Antigen TitersSarah Schmidt, Meron Mengistu, Stephane Daffis, et al.
JHEP Reports : Innovation in Hepatology|March 13, 2023
Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cellsAbhishek Aggarwal, Pamela M Odorizzi, Jens Brodbeck, et al.
Journal of Hepatology|December 17, 2017
Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanismCongrong Niu, Li Li, Stephane Daffis, et al.
International Angiology : a Journal of the International Union of Angiology|July 9, 2016
Prioritization of treatments for lower extremity peripheral artery disease in low- and middle-income countriesF Gerald Fowkes, Rachel B Forster, Carol E Levin, et al.
Journal of Hepatology|January 7, 2015
Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis BStephan Menne, Daniel B Tumas, Katherine H Liu, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2021
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infectionNicholas van Buuren, Ricardo Ramirez, Scott Turner, et al.
Plos Pathogens|March 30, 2016
Correction: Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis BSimon P Fletcher, Daniel J Chin, Lore Gruenbaum, et al.
Pageof 61

Showing results (571-580 of 601) with videos related to

Sort By:
Pageof 61
Scientific Reports|March 31, 2018
Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytesJulie Lucifora, Marc Bonnin, Ludovic Aillot, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2024
Selective depletion of HBV-infected hepatocytes by class A capsid assembly modulators requires high levels of intrahepatic HBV core proteinDmytro Kornyeyev, Zhijuan Song, Stacey Eng, et al.
JHEP Reports : Innovation in Hepatology|March 11, 2026
Spatial transcriptional profiling of CHB liver biopsies reveals an undetected population of zonally biased HBV-integrated cellsSangeetha Mahadevan, Ricardo Ramirez, Hatef Mehrabian, et al.
The Journal of Infectious Diseases|August 21, 2023
Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus-Specific CD8 T-Cell Responses and High Anti-Hepatitis B Surface Antigen TitersSarah Schmidt, Meron Mengistu, Stephane Daffis, et al.
JHEP Reports : Innovation in Hepatology|March 13, 2023
Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cellsAbhishek Aggarwal, Pamela M Odorizzi, Jens Brodbeck, et al.
Journal of Hepatology|December 17, 2017
Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanismCongrong Niu, Li Li, Stephane Daffis, et al.
International Angiology : a Journal of the International Union of Angiology|July 9, 2016
Prioritization of treatments for lower extremity peripheral artery disease in low- and middle-income countriesF Gerald Fowkes, Rachel B Forster, Carol E Levin, et al.
Journal of Hepatology|January 7, 2015
Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis BStephan Menne, Daniel B Tumas, Katherine H Liu, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2021
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infectionNicholas van Buuren, Ricardo Ramirez, Scott Turner, et al.
Plos Pathogens|March 30, 2016
Correction: Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis BSimon P Fletcher, Daniel J Chin, Lore Gruenbaum, et al.
Pageof 61